98%
921
2 minutes
20
Objective: Pneumococcal meningitis is a serious infectious disease with a high mortality rate and a global presence, and survivors have different degrees of neurological sequelae as a consequence of the host response to the infection. Progranulin (PGRN) is a multifunctional autocrine growth factor that is also a major immunoregulator. We want to investigate the role for PGRN in Pneumococcal meningitis in vivo and in vitro.
Method: Mouse and cell models were established to explore the protective effect and mechanism of PGRN against pneumococcal meningitis.
Results: Progranulin plays a protective role in pneumococcal meningitis by inhibiting pyroptosis. Pyroptosis resulted from exposure of BV-2 cells to the bacterium and this was confirmed in the in vivo model. Administration of the NLRP3 inflammasome inhibitor MCC950 to mice prior to infection inhibited pyroptosis and protected PGRN -/- mice and BV-2 cell model from meningitis.
Conclusion: This study implicates a protective role for PGRN in pneumococcal meningitis by inhibiting pyroptosis, indicating that PGRN may have therapeutic potential.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11783684 | PMC |
http://dx.doi.org/10.1002/iid3.70140 | DOI Listing |
Math Biosci Eng
July 2025
Department of Mathematics and Applied Mathematics, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa.
In this paper, we present a deterministic model for the population dynamics of HIV/AIDS, wherein some individuals at the severe symptomatic phase of HIV develop serious opportunistic infections (OIs) such cryptococcal, tuberculous, pneumococcal, and other bacterial meningitis due to an inappropriate treatment or lack of counseling. OIs are responsible for significant mortality and disability on individuals with HIV in many countries. Cryptococcal meningitis (CM) is among frequent OIs responsible for significant mortality and disability of individuals with HIV in limited resource settings.
View Article and Find Full Text PDFCase Rep Med
August 2025
Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
A 65-year-old woman presented with pneumococcal sepsis and meningitis. Despite appropriate antimicrobial therapy and intravenous (IV) dexamethasone, her mental status did not improve. Findings of brain imaging were suggestive of cerebral vasculitis.
View Article and Find Full Text PDFEur J Clin Microbiol Infect Dis
September 2025
Department of Health Promotion, Maternal Childhood, Internal Medicine of Excellence G. D'Alessandro, University of Palermo, Palermo, Italy.
Penicillin-resistant pneumococcal meningitis (PRPM) is a challenging and fatal infection. We conducted a multicentre international retrospective study to evaluate the clinical features, outcomes, predictors of outcomes antimicrobial efficacy and drug susceptibility in patients with PRPM. The study, conducted through the "Infectious Diseases-International Research Initiative" across 33 centers in 11 countries, analyzed PRPM patients treated between 2019 and 2024 using univariate and multivariate analyses.
View Article and Find Full Text PDFActa Neurol Belg
September 2025
Antwerp University Hospital, Edegem, Belgium.
Med Microbiol Immunol
August 2025
Grupo Integrado de Pesquisa em Biomarcadores, Instituto René Rachou - Fundação Oswaldo Cruz, Avenida Augusto de Lima nº 1715, Barro Preto, Belo Horizonte, Minas Gerais, Brasil.
Influenza virus and Streptococcus pneumoniae are major respiratory pathogens responsible for significant global mortality. While influenza causes seasonal flu, pneumococcus is associated with pneumonia, meningitis, sepsis, and otitis, often worsening influenza cases through secondary infections. Aiming to develop a bivalent vaccine against these two pathogens, we used reverse genetics to construct a recombinant influenza virus that carries the gene of the pneumococcal PspA protein (Flu-PspA).
View Article and Find Full Text PDF